194 related articles for article (PubMed ID: 21954843)
21. Effect of pioglitazone on insulin resistance in fructose-drinking rats correlates with AGEs/RAGE inhibition and block of NADPH oxidase and NF kappa B activation.
Liu X; Luo D; Zheng M; Hao Y; Hou L; Zhang S
Eur J Pharmacol; 2010 Mar; 629(1-3):153-8. PubMed ID: 20004657
[TBL] [Abstract][Full Text] [Related]
22. Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats.
Yoshioka K; Wakino S; Homma K; Kanda T; Tatematsu S; Hasegawa K; Sugano N; Ito O; Omata K; Saruta T; Hayashi K
Obesity (Silver Spring); 2008 May; 16(5):965-71. PubMed ID: 18277387
[TBL] [Abstract][Full Text] [Related]
23. Pioglitazone alleviates the mitochondrial apoptotic pathway and mito-oxidative damage in the d-galactose-induced mouse model.
Prakash A; Kumar A
Clin Exp Pharmacol Physiol; 2013 Sep; 40(9):644-51. PubMed ID: 23795773
[TBL] [Abstract][Full Text] [Related]
24. Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
Oliveira AC; Bertollo CM; Rocha LT; Nascimento EB; Costa KA; Coelho MM
Eur J Pharmacol; 2007 Apr; 561(1-3):194-201. PubMed ID: 17343847
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone.
Benigni A; Zoja C; Tomasoni S; Campana M; Corna D; Zanchi C; Gagliardini E; Garofano E; Rottoli D; Ito T; Remuzzi G
J Am Soc Nephrol; 2006 Jun; 17(6):1624-32. PubMed ID: 16687628
[TBL] [Abstract][Full Text] [Related]
26. Ageing-related corpora veno-occlusive dysfunction in the rat is ameliorated by pioglitazone.
Kovanecz I; Ferrini MG; Vernet D; Nolazco G; Rajfer J; Gonzalez-Cadavid NF
BJU Int; 2007 Oct; 100(4):867-74. PubMed ID: 17662078
[TBL] [Abstract][Full Text] [Related]
27. Antioxidant properties of pioglitazone limit nicotinamide adenine dinucleotide phosphate hydrogen oxidase and augment superoxide dismutase activity in cardiac allotransplantation.
Hasegawa T; Okada K; Okita Y; Pinsky DJ
J Heart Lung Transplant; 2011 Oct; 30(10):1186-96. PubMed ID: 21962020
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
Doi S; Masaki T; Arakawa T; Takahashi S; Kawai T; Nakashima A; Naito T; Kohno N; Yorioka N
Transplantation; 2007 Jul; 84(2):207-13. PubMed ID: 17667812
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
Shigeto T; Yokoyama Y; Xin B; Mizunuma H
Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
Bernardo A; Bianchi D; Magnaghi V; Minghetti L
J Neuropathol Exp Neurol; 2009 Jul; 68(7):797-808. PubMed ID: 19535992
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
[TBL] [Abstract][Full Text] [Related]
32. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
33. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.
Ye Y; Nishi SP; Manickavasagam S; Lin Y; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):43-53. PubMed ID: 17643887
[TBL] [Abstract][Full Text] [Related]
34. Pioglitazone preserves vein graft integrity in a rat aortic interposition model.
Chen Z; Hasegawa T; Tanaka A; Okita Y; Okada K
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):408-416.e1. PubMed ID: 20189191
[TBL] [Abstract][Full Text] [Related]
35. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
Ghanaat-Pour H; Sjöholm A
Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
[TBL] [Abstract][Full Text] [Related]
37. Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats.
Kume O; Takahashi N; Wakisaka O; Nagano-Torigoe Y; Teshima Y; Nakagawa M; Yufu K; Hara M; Saikawa T; Yoshimatsu H
Heart Rhythm; 2011 Feb; 8(2):278-85. PubMed ID: 21034856
[TBL] [Abstract][Full Text] [Related]
38. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
Kim SK; Zhao ZS; Lee YJ; Lee KE; Kang SM; Choi D; Lim SK; Chung N; Lee HC; Cha BS
Diabetes Metab Res Rev; 2003; 19(6):487-93. PubMed ID: 14648808
[TBL] [Abstract][Full Text] [Related]
39. Pioglitazone reduces secondary brain damage after experimental brain trauma by PPAR-γ-independent mechanisms.
Thal SC; Heinemann M; Luh C; Pieter D; Werner C; Engelhard K
J Neurotrauma; 2011 Jun; 28(6):983-93. PubMed ID: 21501066
[TBL] [Abstract][Full Text] [Related]
40. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.
Werner C; Kamani CH; Gensch C; Böhm M; Laufs U
Diabetes; 2007 Oct; 56(10):2609-15. PubMed ID: 17623816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
